JP2005529079A - 細胞増殖性疾患を処置する化合物および方法 - Google Patents

細胞増殖性疾患を処置する化合物および方法 Download PDF

Info

Publication number
JP2005529079A
JP2005529079A JP2003572976A JP2003572976A JP2005529079A JP 2005529079 A JP2005529079 A JP 2005529079A JP 2003572976 A JP2003572976 A JP 2003572976A JP 2003572976 A JP2003572976 A JP 2003572976A JP 2005529079 A JP2005529079 A JP 2005529079A
Authority
JP
Japan
Prior art keywords
pyran
group
pentyloxy
tetrahydro
indol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003572976A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005529079A5 (enExample
Inventor
ルブラン，ベロニク
ルブロン，ベルトラン
メル−ミロヴァノビッチ，ドミニク
ロペス・ロドリゲス，マリア・ルース
ヴィソ・ベロンダ，アルマ
ボウソレイユ，エリク
ピカール，ヴィルジニー
ピナール・ピネド，マリア・デル・カルメン
タヴェルネ，ティエリー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ExonHit Therapeutics SA
Original Assignee
ExonHit Therapeutics SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ExonHit Therapeutics SA filed Critical ExonHit Therapeutics SA
Publication of JP2005529079A publication Critical patent/JP2005529079A/ja
Publication of JP2005529079A5 publication Critical patent/JP2005529079A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/40—Oxygen atoms attached in positions 3 and 4, e.g. maltol

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP2003572976A 2002-03-01 2003-02-28 細胞増殖性疾患を処置する化合物および方法 Pending JP2005529079A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/085,141 US6552073B1 (en) 2002-03-01 2002-03-01 Compounds and methods of treating cell proliferative diseases
PCT/IB2003/001050 WO2003074508A1 (en) 2002-03-01 2003-02-28 Compounds and methods of treating cell proliferative diseases

Publications (2)

Publication Number Publication Date
JP2005529079A true JP2005529079A (ja) 2005-09-29
JP2005529079A5 JP2005529079A5 (enExample) 2006-04-06

Family

ID=22189708

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003572976A Pending JP2005529079A (ja) 2002-03-01 2003-02-28 細胞増殖性疾患を処置する化合物および方法

Country Status (6)

Country Link
US (2) US6552073B1 (enExample)
EP (1) EP1480966A1 (enExample)
JP (1) JP2005529079A (enExample)
AU (1) AU2003209924A1 (enExample)
CA (1) CA2477003A1 (enExample)
WO (1) WO2003074508A1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006519221A (ja) * 2003-02-28 2006-08-24 エグゾニ・テラピューティック・ソシエテ・アノニム 化合物並びに細胞増殖性疾患、網膜症及び関節炎を処置する方法
JP2019524797A (ja) * 2016-08-23 2019-09-05 ニューリム・ファーマシューティカルズ・リミテッドＮｅｕｒｉｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ． 掻痒症および／または痒みの治療方法

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6552073B1 (en) * 2002-03-01 2003-04-22 Exonhit Therapeutics Sa Compounds and methods of treating cell proliferative diseases
WO2005110399A2 (en) * 2004-04-29 2005-11-24 The Regents Of The University Of California Zinc-binding groups for metalloprotein inhibitors
EP1755586A2 (en) * 2004-04-29 2007-02-28 The Regents of the University of California Hydroxypyridinone, hydroxypyridinethione, pyrone, and thiopyrone metalloprotein inhibitors
DE102007002260A1 (de) 2007-01-16 2008-07-31 Sanofi-Aventis Verwendung von substituierten Pyranonsäurederivaten zur Herstellung von Medikamenten zur Behandlung des Metabolischen Syndroms

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4812584A (en) * 1984-07-11 1989-03-14 G. D. Searle & Co. Aralkoxy and aryloxyalkoxy kojic acid derivatives
US4644071A (en) * 1984-07-11 1987-02-17 G. D. Searle & Co. Aralkoxy and aryloxyalkoxy kojic acid derivatives
US4705871A (en) * 1984-07-11 1987-11-10 G. D. Searle & Co. Aralkoxy and aryloxyalkoxy kojic acid derivatives
PH22520A (en) * 1984-11-12 1988-10-17 Yamanouchi Pharma Co Ltd Heterocyclic compounds having 4-lover alkyl-3-hydroxy-2-lower alkyl phenoxy-lower alkylene-y-group, and process of producing them
US6552073B1 (en) * 2002-03-01 2003-04-22 Exonhit Therapeutics Sa Compounds and methods of treating cell proliferative diseases

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006519221A (ja) * 2003-02-28 2006-08-24 エグゾニ・テラピューティック・ソシエテ・アノニム 化合物並びに細胞増殖性疾患、網膜症及び関節炎を処置する方法
JP2019524797A (ja) * 2016-08-23 2019-09-05 ニューリム・ファーマシューティカルズ・リミテッドＮｅｕｒｉｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ． 掻痒症および／または痒みの治療方法

Also Published As

Publication number Publication date
US6552073B1 (en) 2003-04-22
EP1480966A1 (en) 2004-12-01
WO2003074508A1 (en) 2003-09-12
AU2003209924A1 (en) 2003-09-16
US20050054629A1 (en) 2005-03-10
WO2003074508B1 (en) 2003-11-27
CA2477003A1 (en) 2003-09-12

Similar Documents

Publication Publication Date Title
JP6231226B2 (ja) ピロリジン−２，５−ジオン誘導体、医薬組成物およびｉｄｏ１阻害剤としての使用のための方法
US9890168B2 (en) 2,4-disubstituted 7H-pyrrolo[2,3-d]pyrimidine derivative, preparation method and medicinal use thereof
CN101817833B (zh) Dpp-iv抑制剂
US20170152226A1 (en) Functionalised and substituted indoles as anti-cancer agents
CA3035860A1 (en) Pyridine compound
KR20020068388A (ko) 술폰아미드 함유 복소환 화합물
JP5778297B2 (ja) 癌治療用のｈｄａｃ阻害剤としての新規４−アミノ−ｎ−ヒドロキシ−ベンズアミド
US20220098178A1 (en) Preparation Method for Amide Compound and Application Thereof in Field of Medicine
CA2561406C (en) Heterocyclic compound and anti-malignant-tumor agent comprising the same as effective component
WO2015021894A1 (zh) 新型羟肟酸衍生物及其医疗应用
JP2005529079A (ja) 細胞増殖性疾患を処置する化合物および方法
WO2018229139A1 (en) Novel compounds for use in cancer
CN109748914B (zh) 吡啶并嘧啶类化合物及其应用
KR20100132553A (ko) 신규한 ｎ-(2-아미노-페닐)-아크릴아미드
KR20250023339A (ko) 페닐 트라이아졸 mll1-wdr5 단백질-단백질 상호작용 저해제
US20070117860A1 (en) Bicyclic indolinesulphonamide derivatives
EP3628664A1 (en) Irreversible inhibitors of kras g12c mutant
CN102311447B (zh) 杂环并嘧啶酮类dpp-iv抑制剂
CN114616234B (zh) 磷咪唑并喹啉胺衍生物、及其药物组合物和应用
CN102584679B (zh) 一类苯并咔唑酰胺类化合物、其制备方法和用途
JP2022516922A (ja) フッ素含有置換ベンゾチオフェン化合物ならびにその医薬組成物および応用
JP2025509830A (ja) 血液脳関門を通過するｍｌｌ１－ｗｄｒ５タンパク質間相互作用阻害剤化合物及びそれらの使用
CN108912035B (zh) 一种具备抗肿瘤活性的吲哚酰胺类化合物
WO2003053440A1 (en) Medicinal composition
WO2018201939A1 (zh) 苯并吲唑类衍生物的前药及其制备方法、应用

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060214

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060214

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090908

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20090909

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100223